Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BB Seguridade Participacoes SA

CI vs. BBSEY: Which Stock Is the Better Value Option?

CI vs. BBSEY: Which Stock Should Value Investors Buy Now?

Crocs

CrowdStrike

Ford Motor Company

Micron Technology

Nokia

Valero Energy

The most undervalued stocks to buy right now are trading at attractive valuations and poised for big gains in the future. The post The 7 Most Undervalued Stocks to Buy for June 2022 appeared first on InvestorPlace.

The 7 Most Undervalued Stocks to Buy for June 2022

Cigna (CI) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Why Cigna (CI) Is a Great Growth Stock

BLOOMFIELD, Conn. , May 24, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022 in Rancho Palos Verdes, CA.

Cigna Corporation Announces Appearance at the Goldman Sachs 43rd Annual Global Healthcare Conference

Ingredion

MetLife

Regeneron Pharmaceuticals

Weis Markets

Certain predators can't see their prey if the prey holds still.

My 'Do Nothing Club' Returned 68% in the Past Year

Costco

Coursera

Green Dot

ZoomInfo Technologies

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, including Costco & Cigna.

Top Wall Street analysts say these stocks are extremely undervalued

It is times like this when following the money can give the best returns and the money is flowing toward Cigna (NYSE: CI). The company released a better than expected earnings report and raised its guidance sparking yet another wave of analysts upgrades and price target revisions.

Follow The Money To Cigna

Cigna Corp. included adjusted revenue in its first-quarter earnings published on Friday, a metric that does not conform with the Securities and Exchange Commission's guidelines on how companies are allowed to use nonstandard numbers in their financial reporting, according to experts.

Called to Account: Cigna again adjusts revenue in quarterly earnings in a way that does not conform with SEC rules, experts say

Health insurer Cigna Corporation (NYSE:CI) closed up 5.88% on Friday, making it among the top S&P gainers. The gains came at the back of an adjusted profit of $6.01 per share in the first quarter.

Hold Cigna stock as it eyes a breakout after boosted outlook

Cigna's (CI) first-quarter results gain momentum from strong performances in Evernorth and Cigna Healthcare segments. A raised EPS outlook for 2022 remains noteworthy.

Cigna (CI) Q1 Earnings Beat on High Membership, Ups '22 EPS View

Cigna Corporation (NYSE:CI ) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman & Chief Executive Officer Brian Evanko - Chief Financial Officer Conference Call Participants Matthew Borsch - BMO Capital Markets Stephen Baxter - Wells Fargo Nathan Rich - Goldman Sachs Josh Raskin - Nephron Research Scott Fidel - Stephens Steven Valiquette - Barclays A.J. Rice - Credit Suisse Gary Taylor - Cowen Lisa Gill - JPMorgan Justin Lake - Wolfe Research Kevin Caliendo - UBS Kevin Fischbeck - Bank of America George Hill - Deutsche Bank Ricky Goldwasser - Morgan Stanley Dave Windley - Jefferies Operator Ladies and gentlemen, thank you for standing by for Cigna's First Quarter 2022 Results Review.

Cigna Corporation (CI) CEO David Cordani on Q1 2022 Results - Earnings Call Transcript

Cigna Corp reported better-than-expected first-quarter profit on Friday, helped by growth in its health services unit that includes the pharmacy benefits management business, and modestly raised its full-year adjusted profit forecast.

Cigna reports Q1 profit beat on health services unit strength

Shares of Cigna Corp. CI, -1.40% gained 0.2% in premarket trading Friday, after the health care services company reported first-quarter profit and revenue that rose above expectations, and provided and upbeat full-year earnings outlook. Net income rose to $1.18 billion, or $3.68 a share, from $1.16 billion, or $3.30 a share, in the year-ago period.

Cigna stock gains after big profit beat, upbeat full-year outlook

Total revenues in the first quarter were $44.0 billion, and adjusted revenues1 were $44.1 billion Shareholders' net income for the first quarter was $1.2 billion, or $3.68 per share Adjusted income from operations2 for the first quarter was $1.9 billion, or $6.01 per share Adjusted income from operations2,3 for 2022 is now projected to be at least $22.60 per share3 BLOOMFIELD, Conn. , May 6, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) today reported strong first quarter 2022 results reflecting revenue and earnings growth across its businesses.

Cigna Reports Strong First Quarter 2022 Results, Raises 2022 Outlook

Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Cigna (CI) Might Surprise This Earnings Season

Pilot results showed that 40% of patients with complex cancers benefited from updated treatment guidance Tech-enabled service harnesses the power of Cigna and Evernorth's combined capabilities to support both patients and community oncologists Service enhances Cigna's suite of integrated oncology solutions, which drives better health outcomes for patients throughout cancer journey BLOOMFIELD, Conn. , May 5, 2022 /PRNewswire/ -- Cigna Corporation (NYSE: CI) announced a new service to improve health outcomes for patients with complex cancers.

Cigna Launches Provider Consult Service to Drive Better Outcomes for Cancer Patients, Powered by Evernorth

Cigna's (CI) first-quarter 2022 results are likely to reflect improved pharmacy revenues in the Evernorth business.

Cigna (CI) Eyes Q1 Earnings Beat on Cigna Healthcare Show

BeiGene

EOG Resources

Host Hotels & Resorts

Vertex Pharmaceuticals

Five large-cap companies with a favorable Zacks Rank will report first-quarter earnings results this week. These are: CI, HST, BGNE, VRTX and EOG.

5 Large-Cap Stocks to Buy Ahead of Q1 Earnings This Week

BLOOMFIELD, Conn. , April 27, 2022 /PRNewswire/ -- The Board of Directors of Cigna Corporation (NYSE: CI) today declared a cash dividend of $1.12 per share of Cigna common stock, payable on June 23, 2022 to shareholders of record as of the close of business on June 8, 2022.

CIGNA DECLARES QUARTERLY DIVIDEND

BLOOMFIELD, Conn. , April 26, 2022 /PRNewswire/ -- Cigna Corporation (NYSE: CI), a global health service company, was honored by the Business Group on Health for its commitment to advancing the health and well-being of its workforce.

Cigna Honored by Business Group on Health as Best Employer for Health and Well-being

Here is how Cigna (CI) and Avidbank Holdings Inc. (AVBH) have performed compared to their sector so far this year.

Has Cigna (CI) Outpaced Other Finance Stocks This Year?

Cigna (CI) arm Evernorth partners with integrated health care organization Kaiser Permanente to offer better care to Kaiser members.

Cigna (CI) Evernorth Business Ties Up With Kaiser Permanente

BLOOMFIELD, Conn. , April 20, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the BofA Securities 2022 Healthcare Conference on May 11, 2022 in Las Vegas, NV.

Cigna Corporation Announces Appearance at the BofA Securities 2022 Healthcare Conference

Health insurer Cigna Corp's Evernorth unit would partner with Kaiser Permanente to help patients enrolled in some its rival's health plans gain access to doctors while traveling.

Cigna's Evernorth unit partners with rival Kaiser Permanente

Broad agreement aims to increase convenience and expand affordable access to valuable health benefits and high-quality care to millions more Americans Kaiser Permanente members will benefit from access to Cigna's physician and provider network while traveling, and Evernorth's wide-ranging health services, including its industry-leading Accredo specialty pharmacy BLOOMFIELD, Conn., and OAKLAND, Calif.

News for Cigna Stock (CI)